The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Maintenance therapy with 5-fluoruracil/leucovorin (5FU/LV) plus panitumumab (pmab) or 5FU/LV alone in RAS wildtype (WT) metastatic colorectal cancer (mCRC) - the PANAMA trial (AIO KRK 0212).
 
Dominik Paul Modest
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Merck KGaA; MSD; Pfizer; Pierre Fabre; Roche; SERVIER; Taiho Oncology
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Lilly; Merck; Merck Sharp & Dohme; Onkowissen; Pierre Fabre; Sanofi; SERVIER
Research Funding - Amgen (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER
 
Meinolf Karthaus
No Relationships to Disclose
 
Stefan Frühauf
No Relationships to Disclose
 
Ullrich Graeven
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; MSD Oncology; SERVIER
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Hexal; Johnson & Johnson; Merck KGaA; MSD Oncology
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Merck KGaA
 
Lothar Müller
No Relationships to Disclose
 
Alexander Koenig
No Relationships to Disclose
 
Ludwig Fischer Von Weikersthal
Honoraria - AstraZeneca; Lilly; Novartis; Pierre Fabre; Roche Pharma AG
 
Karel Caca
No Relationships to Disclose
 
Albrecht Kretzschmar
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi
 
Siegfried Haas
No Relationships to Disclose
 
Annika Kurreck
Honoraria - SERVIER
 
Arndt Stahler
No Relationships to Disclose
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; MSD Oncology; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Servier (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical
 
Swantje Held
No Relationships to Disclose
 
Armin Jarosch
No Relationships to Disclose
 
David Horst
No Relationships to Disclose
 
Stefan Kasper
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; Sanofi; SERVIER; Takeda
Research Funding - Merck Serono (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Tanja Trarbach
No Relationships to Disclose